COX-2 was expressed positively in IDC and DCIS in 87 (87%) and 85 (85%) of the cases respectively, similarly to other reports.21,24,33 The data of the present study showed that the COX-2 expression in DCIS and in IDC was frequently higher. This evidence concerns the gene PTGS2 and ductal breast carcinoma in situ.